MGX Metagenomi Therapeutics, Inc.

NASDAQ
$1.10

Metagenomi Therapeutics, Inc. (MGX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with MGX's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 1 buyer in the last 30 days 1 buyer in the last 90 days 3 sellers in the last 90 days
Insiders buying
1
2 transactions
Insiders selling
4
13 transactions
Purchases
$23.4K
20,000 shares
Sales
$33.1K
22,465 shares
Net activity
-$9.7K
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $33.1K 13 transactions · 22,465 shares

Largest single sale: $6.8K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: September 9, 2026 , by Reid Laurence .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Reid Laurence 2 fills Director Buy 20,000 $1.17 $23.4K 20,000
Irish Jian See Remarks Sell 2,140 $1.16 $2.5K 375,393 −0.6% of holding
Wapnick Pamela Chief Financial Officer Sell 1,911 $1.16 $2.2K 206,580 −0.9% of holding
Wein Matthew See Remarks Sell 358 $1.16 $415 126,133 −0.3% of holding
Irish Jian See Remarks Sell 3,737 $1.30 $4.9K 377,533 −1% of holding
Wapnick Pamela Chief Financial Officer Sell 2,884 $1.30 $3.7K 208,491 −1.4% of holding
Wein Matthew See Remarks Sell 558 $1.30 $725 126,491 −0.4% of holding
Irish Jian Chief Executive Officer Sell 1,607 $1.60 $2.6K 333,770 −0.5% of holding
Wapnick Pamela Chief Financial Officer Sell 1,581 $1.60 $2.5K 187,375 −0.8% of holding
Wein Matthew See Remarks Sell 482 $1.60 $771 114,549 −0.4% of holding
Thomas Brian C. Director Sell 3,830 $1.77 $6.8K 2,510,960 −0.2% of holding
Irish Jian Chief Executive Officer Sell 1,602 $1.77 $2.8K 563,839 −0.3% of holding
Wapnick Pamela Chief Financial Officer Sell 1,576 $1.77 $2.8K 188,956 −0.8% of holding
Wein Matthew See Remarks Sell 199 $1.77 $353 115,031 −0.2% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.